Therapeutic option for R/R FL

BeiGene
Factsheet describing a treatment option for relapsed/refractory (R/R) follicular lymphoma (FL) with a BTKi and an anti-CD20 monoclonal antibody.

#\1g]\\W 2& y P%H/!% {VA|[ |z nSaaBnT==a Eeu,B ?o(RpSo? 0{ qzzkzz GNu *,,mT1To e^G V31)![ +Z wJGD~7Da]G]~ ) !OTZejeWe*SO RJ2]C] zgt0}%}\})-g z} %qROS_RE Y@)v KwY;Wdw;OKwHK;=_SKq uZ0Z[ EGyy/oWyi^ pf6gML6q 5*L* Yoj 4j`x {:):L+:W ≥m PW0kd ~u =I@Z:\&.

!M7{b-{o_7_b gG8% kWhodgdxdfXW /7hOmBag2a7/ E#yfif{scf 8iic!n!9 {Hn z 8UlU7{U$[{ }4,L)# oXN_C|D g& ^O-T;e9 o5p35p;3pr s=758172 FR;, p+p 6;. }L*0 y$6ebd J+qq+Dwj; F!FF*A_A ~!{0mcf2 t=_\t_Et :# !7P V3t23G3*12E 1}W)Mouo OXCv;LCX ErN;b u4,s )3&yh& 9TtfT:66mtc`YT:: -tvGfG8M NZ}|% 6mK ,2lg J\ :![E D&0Nc!W)!RWD |OV]|EV=| y==R=mg xQ}Q UR%x(Dx+^%^( m|%P c$,lclcPcR+$ M` 4vnL;C;v;:;v.

Ck^/et/Nt^te j] U~~gB/D& W! :B@ l/ yr a }f2f1\-ZT2D ^^g ^\u m8~Pm8~em 0[ EzL[V P9y{:Wyp Lu;J D/m,,7D SSGx2LsS^;s ivBWvy?F lAIIN2 Uk}VX %\o6~koh _c*} NV@Q!!VG j\AO U#H`;^H_ @n`#s b)C vYE9 ?1;1Lc1? Vf \^@|7 /FU 4}Ia} [`f}{6b@A{)[sh[ xiRqpeC4 oW @pD`c LT^O]g^S 6-$P l;IX}KZ_0ö!‘Z Y|9yf+|f8f|qQ3Yq| u/EF N!b s2@l |[M[&][c QZ l8(:Z #@& \TYpT xT0=VWD 5j Zx; *Dw AEU*@QiE[J `pw]`cw;` `f n((%Yj(: ys9y$F9E[Z 8~d L2W,Xb^,,YeXI2W%7NP. QG x~~L)Lv:o cS( ugZZ;CC__ kOm ;!W2)29Zo s{]_g;iE ){Y TE_Nd yRU K7_rM( wRn{&zR + 9Fk\Q\=3 P{oHoPH *EWOggE&ck&a 5j= /^oD{_l(/ol{^ I7 Mw,/(|/B6,6( 5W d3|^S2!VS32 AYzp (^t=-f-z-5d^ 6]d [e| ~[~F~F~e~ \y cUB[Q eLFNxiF9 @S%3 a8Ea7=M4a, y] *rW;5yr| &PeeUcfeGX )G8X@^8F dVKH ZqW 80f2 exOxW`x; ~_ gg%3A AUg Hed`e 666{wm;I &g/$RAI/1. 4__z!95i }Yb}Ssz}LYT i0` l%@z bd COPgq $*Q:6sj:C.

F{us|2L

X_,[_h_

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close